微调工厂通过小RNA操纵进行有价值的二次代谢物生物合成:战略和潜在的潜力
Nur Irdina Izzatie Mohd Zahid1, Syed Muhammad Iqbal Syed Othman1, Arif Faisal Mustaffa1
1Department of Biological Sciences and Biotechnology, Faculty of Science and Technology, Universiti Kebangsaan Malaysia (UKM), 43600, Bangi, Selangor, Malaysia.
Planta
|September 10, 2024
概括
小RNAs (sRNA) 调节植物的二次代谢物生产. 操纵这些小RNA (microRNA和小干扰RNA) 提供了一个强大的生物技术工具,用于增强各种行业有价值化合物的生物合成.
科学领域:
- 植物分子生物学 植物分子生物学
- 生物技术是生物技术.
- 代谢学 代谢学 代谢学
背景情况:
- 植物合成的二次代谢物对防御和医药,化品和食品中的应用至关重要.
- 小RNAs (sRNAs),包括microRNAs (miRNAs) 和小干扰RNAs (siRNAs),是基因表达的关键转录后调节者.
- sRNA 向特定的基因和转录因子,参与代谢途径,影响二次代谢产物.
研究的目的:
- 审查目前操纵sRNA调节植物中二次代谢物生物合成的策略.
- 探索参与非模型植物物种中二次代谢产生的sRNA的鉴定.
- 突出未来的研究方向,用于sRNA操纵在生产高价值的植物衍生化合物.
主要方法:
- 对植物二次新陈代谢中sRNA操纵技术的现有文献的审查.
- 分析各种植物物种中sRNA识别和表征的研究策略.
- 讨论提高植物化合物的sRNA介导生物合成的生物技术方法.
主要成果:
- sRNA操纵为增强植物二次代谢物生产提供了一个有希望的途径.
- 确定参与调节关键生物合成途径的特定sRNA是至关重要的.
- 目前的研究表明sRNAs有潜力调节有价值化合物的产生.
结论:
- 操纵sRNA提供了一个强大的生物技术工具,以增加高价值植物二次代谢物的产量.
- 未来的研究应该专注于先进的sRNA策略,以有针对性地生产用于制药,营养药和化品应用的化合物.
- 这种方法对植物产品的可持续生产具有重大潜力.
相关概念视频
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
siRNA - Small Interfering RNAs
16.6K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.6K
Small interfering RNAs (siRNA)
3.5K
3.5K
RNA Interference
26.0K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.0K
Types of RNA
63.4K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
63.4K


